WS #13329
Reports of $400B merger talks between AstraZeneca and Bristol Myers; AZN falls ~9% on skepticism, BMY rises on premium hopes. Two deaths in Michigan linked to cyclospora outbreak, potentially pressuring produce companies like Taylor Farms.
AstraZeneca-Bristol Myers merger talks
Reports of $400B merger talks between AstraZeneca and Bristol Myers; AZN falls ~9% on skepticism, BMY rises on premium hopes.
Two deaths in Michigan linked to cyclospora outbreak, potentially pressuring produce companies like Taylor Farms.